Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
<h4>Background</h4> <p>The factors determining differential HIV disease outcome among individuals expressing protective HLA alleles such as HLA-B*27:05 and HLA-B*57:01 remain unknown. We here analyse two HIV-infected subjects expressing both HLA-B*27:05 and HLA-B*57:01. One subjec...
Main Authors: | Brener, J, Gall, A, Hurst, J, Batorsky, R, Lavandier, N, Chen, F, Edwards, A, Bolton, C, Dsouza, R, Allen, T, Pybus, O, Kellam, P, Matthews, P, Goulder, P |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BioMed Central
2018
|
Similar Items
-
Viral Evasion of Immune Control Mediated by Coexpression of HLA-B*27:05 and HLA-B*57:01
by: Brener, J, et al.
Published: (2013) -
HLA-specific intracellular epitope processing shapes an immunodominance pattern for HLA-B*57 that is distinct from HLA-B*58:01.
by: Kløverpris, H, et al.
Published: (2013) -
Unravelling the Proteomics of HLA-B*57:01<sup>+</sup> Antigen Presenting Cells during Abacavir Medication
by: Funmilola Josephine Haukamp, et al.
Published: (2022-01-01) -
HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.
by: Kloverpris, H, et al.
Published: (2012) -
Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.
by: Crawford, H, et al.
Published: (2009)